Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-30 Sale |
2023-11-01 6:21 pm |
Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks |
9,586 | $6.8306 | $65,478 | 312,352 (Indirect Direct) |
View |
| 2023-10-03 Purchase |
2023-10-05 7:56 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
20,066 | $8.3811 | $168,175 | 225,738 (Indirect Direct) |
View |
| 2023-01-05 Purchase |
2023-01-09 5:55 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
2,000 | $10.41 | $20,811 | 18,000 (Indirect) |
View |
| 2022-12-28 Purchase |
2022-12-30 7:01 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
4,000 | $9.75 | $39,000 | 17,000 (Indirect) |
View |
| 2022-12-01 Purchase |
2022-12-15 6:15 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
10,000 | $12.37 | $123,700 | 15,000 (Indirect) |
View |
| 2022-12-05 Purchase |
2022-12-07 4:30 pm |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
1,250,000 | $12 | $15,000,000 | 5,362,870 (Indirect) |
View |
| 2022-10-31 Sale |
2022-11-02 8:39 pm |
Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer |
2,015 | $12.45 | $25,090 | 24,235 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 8:38 pm |
Aura Biosciences Inc. | AURA | Rich Cadmus See Remarks |
1,672 | $12.45 | $20,813 | 24,578 (Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 8:37 pm |
Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks |
5,706 | $12.46 | $71,082 | 200,063 (Indirect Direct) |
View |
| 2022-10-31 Sale |
2022-11-02 8:36 pm |
Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer |
1,115 | $12.46 | $13,890 | 16,385 (Direct) |
View |
| 2022-06-10 Purchase |
2022-06-14 9:29 pm |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
50,000 | $14.33 | $716,300 | 40,000 (Indirect Direct) |
View |
| 2021-11-02 Purchase |
2021-11-04 5:00 pm |
Aura Biosciences Inc. | AURA | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd 10% Owner |
710,000 | $14 | $9,940,000 | 70,540 (Indirect) |
View |
| 2021-11-02 Purchase |
2021-11-04 4:44 pm |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
1,785,000 | $14 | $24,990,000 | 4,112,870 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-07 Option Award |
2023-06-09 4:57 pm |
N/A 2033-06-07 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:56 pm |
N/A 2033-06-07 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:56 pm |
N/A 2033-06-07 |
Aura Biosciences Inc. | AURA | PAREKH RAJESH B Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-06-07 Option Award |
2023-06-09 4:54 pm |
N/A 2033-06-07 |
Aura Biosciences Inc. | AURA | Srivastava Sapna Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:38 pm |
N/A 2033-01-18 |
Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer |
123,750 | $0 | 147,985 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:36 pm |
N/A 2033-01-18 |
Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer |
107,250 | $0 | 123,635 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:35 pm |
N/A 2033-01-18 |
Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks |
309,375 | $0 | 509,438 (Direct) |
View |
| 2023-01-19 Option Award |
2023-01-23 6:34 pm |
N/A 2033-01-18 |
Aura Biosciences Inc. | AURA | Rich Cadmus See Remarks |
86,625 | $0 | 111,203 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:09 pm |
N/A 2032-06-15 |
Aura Biosciences Inc. | AURA | PAREKH RAJESH B Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:07 pm |
N/A 2032-06-15 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
16,000 | $0 | 205,672 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:07 pm |
N/A 2032-06-15 |
Aura Biosciences Inc. | AURA | Srivastava Sapna Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2022-06-15 Option Award |
2022-06-17 5:06 pm |
N/A 2032-06-15 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-11-02 Conversion |
2021-11-04 5:00 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi Growth I GP Ltd 10% Owner |
4,659,784 | $0 | 70,540 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-04 4:44 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
2,327,870 | $0 | 4,112,870 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-02 4:13 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks |
9,104 | $0 | 205,769 (Indirect) |
View |
| 2021-11-02 Conversion |
2021-11-02 4:11 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
139,672 | $0 | 139,672 (Indirect) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:33 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Johnson David Michael Director |
24,000 | $0 | 24,000 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:32 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Rich Cadmus See Remarks |
138,750 | $0 | 138,750 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:28 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | de los Pinos Elisabet See Remarks |
393,107 | $0 | 519,967 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:28 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | De Rosch Mark Chief Operating Officer |
92,500 | $0 | 92,500 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:27 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Mattessich Antony C. Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:24 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer |
138,750 | $0 | 138,750 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:23 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | PAREKH RAJESH B Director |
16,000 | $0 | 16,000 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:23 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Primiano Christopher Brett Chief Business Officer |
46,250 | $0 | 46,250 (Direct) |
View |
| 2021-10-28 Option Award |
2021-10-29 7:18 pm |
N/A 2031-10-27 |
Aura Biosciences Inc. | AURA | Srivastava Sapna Director |
16,000 | $0 | 16,000 (Direct) |
View |
Ownership |
2021-10-28 8:39 pm |
N/A N/A |
Aura Biosciences Inc. | AURA | Matrix Capital Management Company LP GOEL DAVID E. 10% Owner |
0 | $0 | 2,327,870 (Indirect) |
View |
Ownership |
2021-10-28 8:34 pm |
N/A 2028-10-03 |
Aura Biosciences Inc. | AURA | Feder Julie B Chief Financial Officer |
0 | $0 | 268,442 (Direct) |
View |
Ownership |
2021-10-28 8:30 pm |
N/A 2027-10-11 |
Aura Biosciences Inc. | AURA | Rich Cadmus See Remarks |
0 | $0 | 294,705 (Direct) |
View |